The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation

Yigit Z., Kucukoglu M., Okcun B., Sansoy V., Guzelsoy D.

JAPANESE HEART JOURNAL, cilt.44, sa.3, ss.369-377, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 3
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1536/jhj.44.369
  • Dergi Adı: JAPANESE HEART JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.369-377
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Transesophageal echocardiography (TEE) guided early cardioversion (CV) in conjunction with short-term anticoagulation has been shown to be safe, and an alternative to prolonged conventional anticoagulation therapy. Recently, low molecular weight heparins (LMWHs) have been used successfully as an alternative to standard heparin therapy obviating the need for hospitalization and APTT monitoring. The aim of this study was to determine the feasibility and safety of TEE guided early cardioversion in conjunction with short-term LMWH use in patients with nonvalvular atrial fibrillation (NVAF).